Neumora Therapeutics is a clinical-stage biopharmaceutical company dedicated to addressing the global brain disease crisis through innovative treatment development. The company focuses on creating novel therapies for a wide range of neuropsychiatric disorders and neurodegenerative diseases, utilizing advanced translational, clinical, and computational tools to enable precision medicine. Neumora's mission is to redefine neuroscience drug development, aiming to improve treatment outcomes and enhance the quality of life for patients suffering from brain diseases. The company is committed to fostering a diverse and inclusive workplace, ensuring equal opportunity for all employees and applicants.